...and commercialize its pan receptor interacting molecule (PRIM) program. PRIM is a recombinant immunoglobulin that AB Biosciences...
...in preclinical models of autoimmune and inflammatory diseases compared with approved IV immunoglobulin (IVIG) therapies. AB Biosciences...
...9, 2014 ). AB Biosciences Inc., Allston, Mass. Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Business: Autoimmune, Inflammation Chris Lieu AB Biosciences Inc. Shire...

...and commercialize its pan receptor interacting molecule (PRIM) program. PRIM is a recombinant immunoglobulin that AB Biosciences...
...in preclinical models of autoimmune and inflammatory diseases compared with approved IV immunoglobulin (IVIG) therapies. AB Biosciences...
...immunoglobulin constant regions that can bind to Fc receptors similarly to that of immune complexes. AB Biosciences...